Clinical Activity and Tolerability of Enzalutamide ( MDV3100) in Patients With Metastatic, Castration- Resistant Prostate Cancer Who Progress After Docetaxel and Abiraterone Treatment

S. Badrising, V. van der Noort, I.M. van Oort, H.P. van den Berg, M. Los, P. Hamberg, J.L. Coenen, A.J.M. van den Eertwegh, I.J. de Jong, E.D. Kerver, H. van Tinteren, A.M. Bergman

Research output: Contribution to journalArticleAcademicpeer-review

127 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)968-975
Issue number7
Publication statusPublished - 2014

Cite this